ALEXANDRIA, Va., July 9 -- United States Patent no. 12,351,635, issued on July 8, was assigned to BERLIN-CHEMIE AG (Berlin).

"Pharmaceutical combinations comprising an anti-LY75 antibody" was invented by Monica Binaschi (Rome), Mario Bigioni (Rome), Giuseppe Merlino (Rome), Cecilia Simonelli (Florence, Italy), Francesco Bertoni (Bellinzona, Switzerland) and Andrea Pellacani (Florence, Italy).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates generally to the fields of immunology and molecular biology. More specifically, provided herein are pharmaceutical combinations comprising (A) antibodies, or antigen-binding portions thereof, directed against LY75, and (B) a second anti-cancer e...